Trial intelligence / Profile preview

Nasal Corticosteroids vs Placebo for Nasal Obstruction in Septal Deviation

NCT02877485Phase 4Completed

Sponsor
Stanford University
Start
Aug 2016
Primary completion
Aug 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of triamcinolone acetonide in nasal obstruction, sponsored by Stanford University. Started Aug 2016; status: completed.

02

Drugs

triamcinolone acetonide
03

Conditions

nasal obstruction

Beyond the preview

Go deeper on NCT02877485.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02877485.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call